Primate Monocytes - CD14, CD16 - Ziegler-Heitbrock


Pro- and anti-inflammatory response in neurological disorders associated to anti-glutamate decarboxylase antibodies.


Rare conditions showing psychiatric symptoms and movement disorders have been linked with the presence of anti-glutamate decarboxylase antibodies. Proinflammatory and antiinflammatory immune responses were assessed in patients with neurological disorders associated to anti-glutamic acid decarboxylase antibodies (NDGAD). Immunoregulatory and proinflammatory cell populations were quantified by flow cytometry. No polarization toward Th1, Th2, or Th17 phenotypes was observed in NDGAD patients. Immunoregulatory responses were significantly reduced for Breg, activated Treg, Tr1, and Th3 cells, suggesting a deficient regulatory response, while intermediate monocyte levels were increased. The reduced levels of regulatory T and B cells suggest an impairment in regulatory immune response, while intermediate monocytes could be playing a role in the increased proinflammatory response.

Authors: Leyva-Hernández J, Rodríguez-Ortiz U, Arce-Sillas A, Álvarez-Luquín DD, Pérez-Correa CA, Vivas-Almazán AV, Gómez-Hollsten SM, Montes-Moratilla EU, Torres-Velasco ME, Rodríguez-Violante M, Adalid-Peralta LV,
Journal: J Neuroimmunol; 2021 Mar 19 ; 355 577550. doi:10.1016/j.jneuroim.2021.577550
Year: 2021
PubMed: PMID: 33799062 (Go to PubMed)